1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Guaifenesin Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 98%-99% 1.2.3 Above 99% 1.3 Market Segment by Application 1.3.1 Global Guaifenesin Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Pharmaceuticals 1.3.3 Personal Care Products 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Guaifenesin Market Size (2017-2028) 2.1.1 Global Guaifenesin Revenue (2017-2028) 2.1.2 Global Guaifenesin Sales (2017-2028) 2.2 Global Guaifenesin Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Guaifenesin Sales by Regions (2017-2022) 2.2.2 Global Guaifenesin Revenue by Regions (2017-2022) 2.3 Global Guaifenesin Market Size Forecast by Region 2.3.1 Global Guaifenesin Sales Forecast by Region (2023-2028) 2.3.2 Global Guaifenesin Revenue Forecast by Region (2023-2028) 2.4 Global Top Guaifenesin Regions (Countries) Ranking by Market Size 2.5 Guaifenesin Market Dynamics 2.5.1 Guaifenesin Market Trends 2.5.2 Guaifenesin Market Drivers 2.5.3 Guaifenesin Market Challenges 2.5.4 Guaifenesin Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Guaifenesin Manufacturers by Sales (2017-2022) 3.1.1 Global Guaifenesin Sales by Manufacturers (2017-2022) 3.1.2 Global Guaifenesin Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Guaifenesin Sales in 2021 3.2 Global Top Manufacturers Guaifenesin by Revenue 3.2.1 Global Guaifenesin Revenue by Manufacturers (2017-2022) 3.2.2 Top Guaifenesin Manufacturers Covered: Ranking by Revenue 3.2.3 Global Guaifenesin Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Guaifenesin Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guaifenesin as of 2021) 3.4 Global Guaifenesin Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Guaifenesin Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Guaifenesin Market 3.7 Key Manufacturers Guaifenesin Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Guaifenesin Market Size by Type 4.1 Global Guaifenesin Historic Market Review by Type (2017-2022) 4.1.1 Global Guaifenesin Sales Market Share by Type (2017-2022) 4.1.2 Global Guaifenesin Revenue Market Share by Type (2017-2022) 4.1.3 Guaifenesin Price by Type (2017-2022) 4.2 Global Guaifenesin Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Guaifenesin Sales Forecast by Type (2023-2028) 4.2.2 Global Guaifenesin Revenue Forecast by Type (2023-2028) 4.2.3 Guaifenesin Price Forecast by Type (2023-2028) 5 Global Guaifenesin Market Size by Application 5.1 Global Guaifenesin Historic Market Review by Application (2017-2022) 5.1.1 Global Guaifenesin Sales Market Share by Application (2017-2022) 5.1.2 Global Guaifenesin Revenue Market Share by Application (2017-2022) 5.1.3 Guaifenesin Price by Application (2017-2022) 5.2 Global Guaifenesin Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Guaifenesin Sales Forecast by Application (2023-2028) 5.2.2 Global Guaifenesin Revenue Forecast by Application (2023-2028) 5.2.3 Guaifenesin Price Forecast by Application (2023-2028) 6 North America 6.1 North America Guaifenesin Sales Breakdown by Company 6.1.1 North America Guaifenesin Sales by Company (2017-2022) 6.1.2 North America Guaifenesin Revenue by Company (2017-2022) 6.2 North America Guaifenesin Market Size by Type 6.2.1 North America Guaifenesin Sales by Type (2017-2028) 6.2.2 North America Guaifenesin Revenue by Type (2017-2028) 6.3 North America Guaifenesin Market Size by Application 6.3.1 North America Guaifenesin Sales by Application (2017-2028) 6.3.2 North America Guaifenesin Revenue by Application (2017-2028) 6.4 North America Guaifenesin Market Size by Country 6.4.1 North America Guaifenesin Sales by Country (2017-2028) 6.4.2 North America Guaifenesin Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Guaifenesin Sales Breakdown by Company 7.1.1 Europe Guaifenesin Sales by Company (2017-2022) 7.1.2 Europe Guaifenesin Revenue by Company (2017-2022) 7.2 Europe Guaifenesin Market Size by Type 7.2.1 Europe Guaifenesin Sales by Type (2017-2028) 7.2.2 Europe Guaifenesin Revenue by Type (2017-2028) 7.3 Europe Guaifenesin Market Size by Application 7.3.1 Europe Guaifenesin Sales by Application (2017-2028) 7.3.2 Europe Guaifenesin Revenue by Application (2017-2028) 7.4 Europe Guaifenesin Market Size by Country 7.4.1 Europe Guaifenesin Sales by Country (2017-2028) 7.4.2 Europe Guaifenesin Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Guaifenesin Sales Breakdown by Company 8.1.1 Asia Pacific Guaifenesin Sales by Company (2017-2022) 8.1.2 Asia Pacific Guaifenesin Revenue by Company (2017-2022) 8.2 Asia Pacific Guaifenesin Market Size by Type 8.2.1 Asia Pacific Guaifenesin Sales by Type (2017-2028) 8.2.2 Asia Pacific Guaifenesin Revenue by Type (2017-2028) 8.3 Asia Pacific Guaifenesin Market Size by Application 8.3.1 Asia Pacific Guaifenesin Sales by Application (2017-2028) 8.3.2 Asia Pacific Guaifenesin Revenue by Application (2017-2028) 8.4 Asia Pacific Guaifenesin Market Size by Region 8.4.1 Asia Pacific Guaifenesin Sales by Region 8.4.2 Asia Pacific Guaifenesin Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Guaifenesin Sales Breakdown by Company 9.1.1 Latin America Guaifenesin Sales by Company (2017-2022) 9.1.2 Latin America Guaifenesin Revenue by Company (2017-2022) 9.2 Latin America Guaifenesin Market Size by Type 9.2.1 Latin America Guaifenesin Sales by Type (2017-2028) 9.2.2 Latin America Guaifenesin Revenue by Type (2017-2028) 9.3 Latin America Guaifenesin Market Size by Application 9.3.1 Latin America Guaifenesin Sales by Application (2017-2028) 9.3.2 Latin America Guaifenesin Revenue by Application (2017-2028) 9.4 Latin America Guaifenesin Market Size by Country 9.4.1 Latin America Guaifenesin Sales by Country (2017-2028) 9.4.2 Latin America Guaifenesin Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Guaifenesin Sales Breakdown by Company 10.1.1 Middle East and Africa Guaifenesin Sales by Company (2017-2022) 10.1.2 Middle East and Africa Guaifenesin Revenue by Company (2017-2022) 10.2 Middle East and Africa Guaifenesin Market Size by Type 10.2.1 Middle East and Africa Guaifenesin Sales by Type (2017-2028) 10.2.2 Middle East and Africa Guaifenesin Revenue by Type (2017-2028) 10.3 Middle East and Africa Guaifenesin Market Size by Application 10.3.1 Middle East and Africa Guaifenesin Sales by Application (2017-2028) 10.3.2 Middle East and Africa Guaifenesin Revenue by Application (2017-2028) 10.4 Middle East and Africa Guaifenesin Market Size by Country 10.4.1 Middle East and Africa Guaifenesin Sales by Country (2017-2028) 10.4.2 Middle East and Africa Guaifenesin Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Granules 11.1.1 Granules Corporation Information 11.1.2 Granules Overview 11.1.3 Granules Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Granules Guaifenesin Products and Services 11.1.5 Granules Guaifenesin SWOT Analysis 11.1.6 Granules Recent Developments 11.2 Synthokem Labs 11.2.1 Synthokem Labs Corporation Information 11.2.2 Synthokem Labs Overview 11.2.3 Synthokem Labs Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Synthokem Labs Guaifenesin Products and Services 11.2.5 Synthokem Labs Guaifenesin SWOT Analysis 11.2.6 Synthokem Labs Recent Developments 11.3 Haizhou Pharma 11.3.1 Haizhou Pharma Corporation Information 11.3.2 Haizhou Pharma Overview 11.3.3 Haizhou Pharma Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Haizhou Pharma Guaifenesin Products and Services 11.3.5 Haizhou Pharma Guaifenesin SWOT Analysis 11.3.6 Haizhou Pharma Recent Developments 11.4 Yuan Cheng Group 11.4.1 Yuan Cheng Group Corporation Information 11.4.2 Yuan Cheng Group Overview 11.4.3 Yuan Cheng Group Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Yuan Cheng Group Guaifenesin Products and Services 11.4.5 Yuan Cheng Group Guaifenesin SWOT Analysis 11.4.6 Yuan Cheng Group Recent Developments 11.5 Stellar Chemical 11.5.1 Stellar Chemical Corporation Information 11.5.2 Stellar Chemical Overview 11.5.3 Stellar Chemical Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Stellar Chemical Guaifenesin Products and Services 11.5.5 Stellar Chemical Guaifenesin SWOT Analysis 11.5.6 Stellar Chemical Recent Developments 11.6 Biesterfeld 11.6.1 Biesterfeld Corporation Information 11.6.2 Biesterfeld Overview 11.6.3 Biesterfeld Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Biesterfeld Guaifenesin Products and Services 11.6.5 Biesterfeld Guaifenesin SWOT Analysis 11.6.6 Biesterfeld Recent Developments 11.7 Seven Star Pharma 11.7.1 Seven Star Pharma Corporation Information 11.7.2 Seven Star Pharma Overview 11.7.3 Seven Star Pharma Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Seven Star Pharma Guaifenesin Products and Services 11.7.5 Seven Star Pharma Guaifenesin SWOT Analysis 11.7.6 Seven Star Pharma Recent Developments 11.8 Camlin Fine Science 11.8.1 Camlin Fine Science Corporation Information 11.8.2 Camlin Fine Science Overview 11.8.3 Camlin Fine Science Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Camlin Fine Science Guaifenesin Products and Services 11.8.5 Camlin Fine Science Guaifenesin SWOT Analysis 11.8.6 Camlin Fine Science Recent Developments 11.9 Gennex Lab 11.9.1 Gennex Lab Corporation Information 11.9.2 Gennex Lab Overview 11.9.3 Gennex Lab Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Gennex Lab Guaifenesin Products and Services 11.9.5 Gennex Lab Guaifenesin SWOT Analysis 11.9.6 Gennex Lab Recent Developments 11.10 Iwaki Seiyaku 11.10.1 Iwaki Seiyaku Corporation Information 11.10.2 Iwaki Seiyaku Overview 11.10.3 Iwaki Seiyaku Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Iwaki Seiyaku Guaifenesin Products and Services 11.10.5 Iwaki Seiyaku Guaifenesin SWOT Analysis 11.10.6 Iwaki Seiyaku Recent Developments 11.11 Pan Drugs 11.11.1 Pan Drugs Corporation Information 11.11.2 Pan Drugs Overview 11.11.3 Pan Drugs Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Pan Drugs Guaifenesin Products and Services 11.11.5 Pan Drugs Recent Developments 11.12 Delta Synthetic 11.12.1 Delta Synthetic Corporation Information 11.12.2 Delta Synthetic Overview 11.12.3 Delta Synthetic Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 Delta Synthetic Guaifenesin Products and Services 11.12.5 Delta Synthetic Recent Developments 11.13 Smart Pharm 11.13.1 Smart Pharm Corporation Information 11.13.2 Smart Pharm Overview 11.13.3 Smart Pharm Guaifenesin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Smart Pharm Guaifenesin Products and Services 11.13.5 Smart Pharm Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Guaifenesin Value Chain Analysis 12.2 Guaifenesin Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Guaifenesin Production Mode & Process 12.4 Guaifenesin Sales and Marketing 12.4.1 Guaifenesin Sales Channels 12.4.2 Guaifenesin Distributors 12.5 Guaifenesin Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Guaifenesin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 98%-99% Table 3. Major Manufacturers of Above 99% Table 4. Global Guaifenesin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Guaifenesin Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Guaifenesin Sales by Region (2017-2022) & (K MT) Table 7. Global Guaifenesin Sales Market Share by Region (2017-2022) Table 8. Global Guaifenesin Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Guaifenesin Revenue Market Share by Region (2017-2022) Table 10. Global Guaifenesin Sales Forecast by Region (2023-2028) & (K MT) Table 11. Global Guaifenesin Sales Market Share Forecast by Region (2023-2028) Table 12. Global Guaifenesin Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global Guaifenesin Revenue Market Share Forecast by Region (2023-2028) Table 14. Top Guaifenesin Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. Guaifenesin Market Trends Table 16. Guaifenesin Market Drivers Table 17. Guaifenesin Market Challenges Table 18. Guaifenesin Market Restraints Table 19. Global Guaifenesin Sales by Manufacturers (2017-2022) & (K MT) Table 20. Global Guaifenesin Sales Share by Manufacturers (2017-2022) Table 21. Global Guaifenesin Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top Guaifenesin Manufacturers by Revenue (US$ Million) in 2021 Table 23. Guaifenesin Revenue Share by Manufacturers (2017-2022) Table 24. Global Guaifenesin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guaifenesin as of 2021) Table 26. Key Manufacturers Guaifenesin Average Selling Price (ASP) & (2017-2022) & (USD/MT) Table 27. Key Manufacturers Guaifenesin Plants/Factories Distribution Table 28. Key Manufacturers Guaifenesin Area Served Table 29. Date of Key Manufacturers Enter into Guaifenesin Market Table 30. Key Manufacturers Guaifenesin Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Guaifenesin Sales (K MT) by Type (2017-2022) Table 33. Global Guaifenesin Sales Share by Type (2017-2022) Table 34. Global Guaifenesin Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global Guaifenesin Price (K MT) by Type (2017-2022) Table 36. Global Guaifenesin Sales (K MT) by Type (2023-2028) Table 37. Global Guaifenesin Sales Share by Type (2023-2028) Table 38. Global Guaifenesin Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global Guaifenesin Revenue Share by Type (2023-2028) Table 40. Global Guaifenesin Price (K MT) by Type (2023-2028) Table 41. Global Guaifenesin Sales (K MT) by Application (2017-2022) Table 42. Global Guaifenesin Sales Share by Application (2017-2022) Table 43. Global Guaifenesin Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global Guaifenesin Price (K MT) by Application (2017-2022) Table 45. Global Guaifenesin Sales (K MT) by Application (2023-2028) Table 46. Global Guaifenesin Sales Share by Application (2023-2028) Table 47. Global Guaifenesin Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global Guaifenesin Revenue Share by Application (2023-2028) Table 49. Global Guaifenesin Price (K MT) by Application (2023-2028) Table 50. North America Guaifenesin Sales by Company (2017-2022) & (K MT) Table 51. North America Guaifenesin Sales Market Share by Company (2017-2022) Table 52. North America Guaifenesin Revenue by Company (2017-2022) & (US$ Million) Table 53. North America Guaifenesin Revenue Market Share by Company (2017-2022) Table 54. North America Guaifenesin Sales by Type (2017-2022) & (K MT) Table 55. North America Guaifenesin Sales by Type (2023-2028) & (K MT) Table 56. North America Guaifenesin Revenue by Type (2017-2022) & (US$ Million) Table 57. North America Guaifenesin Revenue by Type (2023-2028) & (US$ Million) Table 58. North America Guaifenesin Sales by Application (2017-2022) & (K MT) Table 59. North America Guaifenesin Sales by Application (2023-2028) & (K MT) Table 60. North America Guaifenesin Revenue by Application (2017-2022) & (US$ Million) Table 61. North America Guaifenesin Revenue by Application (2023-2028) & (US$ Million) Table 62. North America Guaifenesin Sales by Country (2017-2022) & (K MT) Table 63. North America Guaifenesin Sales by Country (2023-2028) & (K MT) Table 64. North America Guaifenesin Revenue by Country (2017-2022) & (US$ Million) Table 65. North America Guaifenesin Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe Guaifenesin Sales by Company (2017-2022) & (K MT) Table 67. Europe Guaifenesin Sales Market Share by Company (2017-2022) Table 68. Europe Guaifenesin Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe Guaifenesin Revenue Market Share by Company (2017-2022) Table 70. Europe Guaifenesin Sales by Type (2017-2022) & (K MT) Table 71. Europe Guaifenesin Sales by Type (2023-2028) & (K MT) Table 72. Europe Guaifenesin Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe Guaifenesin Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe Guaifenesin Sales by Application (2017-2022) & (K MT) Table 75. Europe Guaifenesin Sales by Application (2023-2028) & (K MT) Table 76. Europe Guaifenesin Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe Guaifenesin Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe Guaifenesin Sales by Country (2017-2022) & (K MT) Table 79. Europe Guaifenesin Sales by Country (2023-2028) & (K MT) Table 80. Europe Guaifenesin Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe Guaifenesin Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific Guaifenesin Sales by Company (2017-2022) & (K MT) Table 83. Asia Pacific Guaifenesin Sales Market Share by Company (2017-2022) Table 84. Asia Pacific Guaifenesin Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific Guaifenesin Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific Guaifenesin Sales by Type (2017-2022) & (K MT) Table 87. Asia Pacific Guaifenesin Sales by Type (2023-2028) & (K MT) Table 88. Asia Pacific Guaifenesin Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific Guaifenesin Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific Guaifenesin Sales by Application (2017-2022) & (K MT) Table 91. Asia Pacific Guaifenesin Sales by Application (2023-2028) & (K MT) Table 92. Asia Pacific Guaifenesin Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific Guaifenesin Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific Guaifenesin Sales by Region (2017-2022) & (K MT) Table 95. Asia Pacific Guaifenesin Sales by Region (2023-2028) & (K MT) Table 96. Asia Pacific Guaifenesin Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific Guaifenesin Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America Guaifenesin Sales by Company (2017-2022) & (K MT) Table 99. Latin America Guaifenesin Sales Market Share by Company (2017-2022) Table 100. Latin America Guaifenesin Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America Guaifenesin Revenue Market Share by Company (2017-2022) Table 102. Latin America Guaifenesin Sales by Type (2017-2022) & (K MT) Table 103. Latin America Guaifenesin Sales by Type (2023-2028) & (K MT) Table 104. Latin America Guaifenesin Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America Guaifenesin Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America Guaifenesin Sales by Application (2017-2022) & (K MT) Table 107. Latin America Guaifenesin Sales by Application (2023-2028) & (K MT) Table 108. Latin America Guaifenesin Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America Guaifenesin Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America Guaifenesin Sales by Country (2017-2022) & (K MT) Table 111. Latin America Guaifenesin Sales by Country (2023-2028) & (K MT) Table 112. Latin America Guaifenesin Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America Guaifenesin Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa Guaifenesin Sales by Company (2017-2022) & (K MT) Table 115. Middle East and Africa Guaifenesin Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa Guaifenesin Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa Guaifenesin Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa Guaifenesin Sales by Type (2017-2022) & (K MT) Table 119. Middle East and Africa Guaifenesin Sales by Type (2023-2028) & (K MT) Table 120. Middle East and Africa Guaifenesin Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa Guaifenesin Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa Guaifenesin Sales by Application (2017-2022) & (K MT) Table 123. Middle East and Africa Guaifenesin Sales by Application (2023-2028) & (K MT) Table 124. Middle East and Africa Guaifenesin Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa Guaifenesin Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa Guaifenesin Sales by Country (2017-2022) & (K MT) Table 127. Middle East and Africa Guaifenesin Sales by Country (2023-2028) & (K MT) Table 128. Middle East and Africa Guaifenesin Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa Guaifenesin Revenue by Country (2023-2028) & (US$ Million) Table 130. Granules Corporation Information Table 131. Granules Description and Overview Table 132. Granules Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 133. Granules Guaifenesin Product and Services Table 134. Granules Guaifenesin SWOT Analysis Table 135. Granules Recent Developments Table 136. Synthokem Labs Corporation Information Table 137. Synthokem Labs Description and Overview Table 138. Synthokem Labs Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 139. Synthokem Labs Guaifenesin Product and Services Table 140. Synthokem Labs Guaifenesin SWOT Analysis Table 141. Synthokem Labs Recent Developments Table 142. Haizhou Pharma Corporation Information Table 143. Haizhou Pharma Description and Overview Table 144. Haizhou Pharma Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 145. Haizhou Pharma Guaifenesin Product and Services Table 146. Haizhou Pharma Guaifenesin SWOT Analysis Table 147. Haizhou Pharma Recent Developments Table 148. Yuan Cheng Group Corporation Information Table 149. Yuan Cheng Group Description and Overview Table 150. Yuan Cheng Group Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 151. Yuan Cheng Group Guaifenesin Product and Services Table 152. Yuan Cheng Group Guaifenesin SWOT Analysis Table 153. Yuan Cheng Group Recent Developments Table 154. Stellar Chemical Corporation Information Table 155. Stellar Chemical Description and Overview Table 156. Stellar Chemical Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 157. Stellar Chemical Guaifenesin Product and Services Table 158. Stellar Chemical Guaifenesin SWOT Analysis Table 159. Stellar Chemical Recent Developments Table 160. Biesterfeld Corporation Information Table 161. Biesterfeld Description and Overview Table 162. Biesterfeld Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 163. Biesterfeld Guaifenesin Product and Services Table 164. Biesterfeld Guaifenesin SWOT Analysis Table 165. Biesterfeld Recent Developments Table 166. Seven Star Pharma Corporation Information Table 167. Seven Star Pharma Description and Overview Table 168. Seven Star Pharma Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 169. Seven Star Pharma Guaifenesin Product and Services Table 170. Seven Star Pharma Guaifenesin SWOT Analysis Table 171. Seven Star Pharma Recent Developments Table 172. Camlin Fine Science Corporation Information Table 173. Camlin Fine Science Description and Overview Table 174. Camlin Fine Science Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 175. Camlin Fine Science Guaifenesin Product and Services Table 176. Camlin Fine Science Guaifenesin SWOT Analysis Table 177. Camlin Fine Science Recent Developments Table 178. Gennex Lab Corporation Information Table 179. Gennex Lab Description and Overview Table 180. Gennex Lab Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 181. Gennex Lab Guaifenesin Product and Services Table 182. Gennex Lab Guaifenesin SWOT Analysis Table 183. Gennex Lab Recent Developments Table 184. Iwaki Seiyaku Corporation Information Table 185. Iwaki Seiyaku Description and Overview Table 186. Iwaki Seiyaku Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 187. Iwaki Seiyaku Guaifenesin Product and Services Table 188. Iwaki Seiyaku Guaifenesin SWOT Analysis Table 189. Iwaki Seiyaku Recent Developments Table 190. Pan Drugs Corporation Information Table 191. Pan Drugs Description and Overview Table 192. Pan Drugs Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 193. Pan Drugs Guaifenesin Product and Services Table 194. Pan Drugs Recent Developments Table 195. Delta Synthetic Corporation Information Table 196. Delta Synthetic Description and Overview Table 197. Delta Synthetic Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 198. Delta Synthetic Guaifenesin Product and Services Table 199. Delta Synthetic Recent Developments Table 200. Smart Pharm Corporation Information Table 201. Smart Pharm Description and Overview Table 202. Smart Pharm Guaifenesin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 203. Smart Pharm Guaifenesin Product and Services Table 204. Smart Pharm Recent Developments Table 205. Key Raw Materials Lists Table 206. Raw Materials Key Suppliers Lists Table 207. Guaifenesin Distributors List Table 208. Guaifenesin Customers List Table 209. Research Programs/Design for This Report Table 210. Key Data Information from Secondary Sources Table 211. Key Data Information from Primary Sources List of Figures Figure 1. Guaifenesin Product Picture Figure 2. Global Guaifenesin Sales Market Share by Type in 2021 & 2028 Figure 3. 98%-99% Product Picture Figure 4. Above 99% Product Picture Figure 5. Global Guaifenesin Sales Market Share by Application in 2021 & 2028 Figure 6. Pharmaceuticals Use Case Figure 7. Personal Care Products Use Case Figure 8. Others Use Case Figure 9. Guaifenesin Report Years Considered Figure 10. Global Guaifenesin Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Guaifenesin Market Size 2017-2028 (US$ Million) Figure 12. Global Guaifenesin Sales (2017-2022) & (K MT) Figure 13. Global Guaifenesin Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Guaifenesin Sales Market Share by Region (2017-2022) Figure 15. Global Guaifenesin Sales Market Share by Region in 2021 Figure 16. Global Guaifenesin Revenue Market Share by Region in 2017 VS 2021 Figure 17. Global Guaifenesin Sales Share by Manufacturers in 2021 Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Guaifenesin Sales in 2021 Figure 19. Guaifenesin Revenue Share by Manufacturers in 2021 Figure 20. Guaifenesin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Guaifenesin Revenue Share by Type (2017-2022) Figure 22. Global Guaifenesin Revenue Growth Rate by Type in 2017 & 2021 Figure 23. Global Guaifenesin Revenue Share by Application (2017-2022) Figure 24. Global Guaifenesin Revenue Growth Rate by Application in 2017 & 2021 Figure 25. North America Guaifenesin Sales Market Share by Type (2017-2028) Figure 26. North America Guaifenesin Revenue Market Share by Type (2017-2028) Figure 27. North America Guaifenesin Sales Market Share by Application (2017-2028) Figure 28. North America Guaifenesin Revenue Market Share by Application (2017-2028) Figure 29. North America Guaifenesin Sales Share by Country (2017-2028) Figure 30. North America Guaifenesin Revenue Share by Country (2017-2028) Figure 31. U.S. Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 32. Canada Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 33. Europe Guaifenesin Sales Market Share by Type (2017-2028) Figure 34. Europe Guaifenesin Revenue Market Share by Type (2017-2028) Figure 35. Europe Guaifenesin Sales Market Share by Application (2017-2028) Figure 36. Europe Guaifenesin Revenue Market Share by Application (2017-2028) Figure 37. Europe Guaifenesin Sales Share by Country (2017-2028) Figure 38. Europe Guaifenesin Revenue Share by Country (2017-2028) Figure 39. Germany Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 40. France Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 41. U.K. Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 42. Italy Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 43. Russia Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 44. Asia Pacific Guaifenesin Sales Market Share by Type (2017-2028) Figure 45. Asia Pacific Guaifenesin Revenue Market Share by Type (2017-2028) Figure 46. Asia Pacific Guaifenesin Sales Market Share by Application (2017-2028) Figure 47. Asia Pacific Guaifenesin Revenue Market Share by Application (2017-2028) Figure 48. Asia Pacific Guaifenesin Sales Share by Region (2017-2028) Figure 49. Asia Pacific Guaifenesin Revenue Share by Region (2017-2028) Figure 50. China Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 51. Japan Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 52. South Korea Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 53. India Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 54. Australia Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 55. Taiwan Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 56. Indonesia Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 57. Thailand Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 58. Malaysia Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 59. Philippines Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 60. Vietnam Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 61. Latin America Guaifenesin Sales Market Share by Type (2017-2028) Figure 62. Latin America Guaifenesin Revenue Market Share by Type (2017-2028) Figure 63. Latin America Guaifenesin Sales Market Share by Application (2017-2028) Figure 64. Latin America Guaifenesin Revenue Market Share by Application (2017-2028) Figure 65. Latin America Guaifenesin Sales Share by Country (2017-2028) Figure 66. Latin America Guaifenesin Revenue Share by Country (2017-2028) Figure 67. Mexico Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 68. Brazil Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 69. Argentina Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 70. Middle East and Africa Guaifenesin Sales Market Share by Type (2017-2028) Figure 71. Middle East and Africa Guaifenesin Revenue Market Share by Type (2017-2028) Figure 72. Middle East and Africa Guaifenesin Sales Market Share by Application (2017-2028) Figure 73. Middle East and Africa Guaifenesin Revenue Market Share by Application (2017-2028) Figure 74. Middle East and Africa Guaifenesin Sales Share by Country (2017-2028) Figure 75. Middle East and Africa Guaifenesin Revenue Share by Country (2017-2028) Figure 76. Turkey Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 77. Saudi Arabia Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 78. UAE Guaifenesin Revenue (2017-2028) & (US$ Million) Figure 79. Guaifenesin Value Chain Figure 80. Guaifenesin Production Process Figure 81. Channels of Distribution Figure 82. Distributors Profiles Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Granules Synthokem Labs Haizhou Pharma Yuan Cheng Group Stellar Chemical Biesterfeld Seven Star Pharma Camlin Fine Science Gennex Lab Iwaki Seiyaku Pan Drugs Delta Synthetic Smart Pharm